Anticonvulsant effects of four linear furanocoumarins, bergapten, imperatorin, oxypeucedanin, and xanthotoxin, in the mouse maximal electroshock-induced seizure model: A comparative study

Pharmacological Reports

Volumn 62, Issue 6, 2010, Pages 1231-1236

  Łuszczki, Jarogniew J ^a,b   Andres Mach, Marta ^b   Gleńsk, Michał ^c   Skalicka Woźniak, Krystyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Bergapten; Imperatorin; Maximal electroshock seizure test; Oxypeucedanin; Xanthotoxin

Indexed keywords

BERGAPTEN; FUROBENZOPYRAN DERIVATIVE; METHOXSALEN; OXYPEUCEDANIN; PENTOSALEN; PSORALEN; UNCLASSIFIED DRUG;

ADULT ANIMAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DOSE TIME EFFECT RELATION; DRUG DETERMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG STRUCTURE; DRUG TREATMENT FAILURE; ELECTRIC SHOCK; EVOKED CORTICAL RESPONSE; EXPERIMENTAL MODEL; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; SYSTEMIC THERAPY; TONIC SEIZURE;

EID: 79551501944     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(10)70387-X     Document Type: Article

References (26)

1. Chen IS, Chang CT, Sheen WS, Teng CM, Tsai IL, Duh CY, Ko FN: Coumarins and antiplatelet aggregation constituents from formosan Peucedanum japonicum. Phytochemistry, 1996, 41, 525-530.
2. Elisabetsky E, Brum LF, Souza DO: Anticonvulsant properties of linalool in glutamate-related seizure models. Phytomedicine, 1999, 6, 107-113.
3. Grynkiewicz G, Gadzikowska M: Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. Pharmacol Rep, 2008, 60, 439-463.
4. Hoult JR, Paya M: Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen Pharmacol, 1996, 27, 713-722.
5. Huen MS, Leung JW, Ng W, Lui WS, Chan MN, Wong JT, Xue H: 5,7-Dihydroxy-6-methoxyflavone, a benzodiazepine site ligand isolated from Scutellaria baicalensis Georgi, with selective antagonistic properties. Biochem Pharmacol, 2003, 66, 125-132.
6. Jastrzȩbska-Wiȩsek M, Librowski T, Czarnecki R, Marona H, Nowak G: Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice. Pol J Pharmacol, 2003, 55, 461-465.
7. Kasture VS, Chopde CT, Deshmukh VK: Anticonvulsive activity of Albizzia lebbeck, Hibiscus rosa sinesis and Butea monosperma in experimental animals. J Ethnopharmacol, 2000, 71, 65-75.
8. Kasture VS, Deshmukh VK, Chopde CT: Anxiolytic and anticonvulsive activity of Sesbania grandiflora leaves in experimental animals. Phytother Res, 2002, 16, 455-460.
9. Kasture VS, Kasture SB, Chopde CT: Anticonvulsive activity of Butea monosperma flowers in laboratory animals. Pharmacol Biochem Behav, 2002, 72, 965-972.
10. Kleiner HE, Vulimiri SV, Starost MF, Reed MJ, DiGiovanni J: Oral administration of the citrus coumarin, isopimpinellin, blocks DNA adduct formation and skin tumor initiation by 7,12-dimethylbenz[a]anthracene in SENCAR mice. Carcinogenesis, 2002, 23, 1667-1675.
11. Kubacka M, Librowski T, Czarnecki R, Fra̧ckowiak B, Lochyński S: Anticonvulsant and antidepressant activity of the selected terpene GABA derivatives in experimental tests in mice. Pharmacol Rep, 2006, 58, 936-943.
12. Lee YY, Lee S, Jin JL, Yun-Choi HS: Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and Angelica gigas. Arch Pharm Res, 2003, 26, 723-726.
13. Librowski T, Czarnecki R, Mendyk A, Jastrzȩbska M: Influence of new monoterpene homologues of GABA on the central nervous system activity in mice. Pol J Pharmacol, 2000, 52, 317-321.
14. Librowski T, Kubacka M, Meusel M, Scolari S, Müller CE, Gütschow M: Evaluation of anticonvulsant and analgesic effects of benzyl- and benzhydryl ureides. Eur J Pharmacol, 2007, 559, 138-149.
15. Löscher W: Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res, 2002, 50, 105-123.
16. Löscher W, Fassbender CP, Nolting B: The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models. Epilepsy Res, 1991, 8, 79-94.
17. Łuszczki JJ, Andres-Mach M, Cisowski W, Mazol I, Głowniak K, Czuczwar SJ: Osthole suppresses seizures in the mouse maximal electroshock seizure model. Eur J Pharmacol, 2009, 607, 107-109.
18. Łuszczki JJ, Głowniak K, Czuczwar SJ: Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice. Eur J Pharmacol, 2007, 574, 133-139.
19. Łuszczki JJ, Głowniak K, Czuczwar SJ: Time-course and dose-response relationships of imperatorin in the mouse maximal electroshock seizure threshold model. Neurosci Res, 2007, 59, 18-22.
20. Łuszczki JJ, Wojda E, Andres-Mach M, Cisowski W, Gleńsk M, Głowniak K, Czuczwar SJ: Anticonvulsant and acute neurotoxic effects of imperatorin, osthole and valproate in the maximal electroshock seizure and chimney tests in mice: A comparative study. Epilepsy Res, 2009, 85, 293-299.
21. Łuszczki JJ, Wojda E, Raszewski G, Głowniak K, Czuczwar SJ: Influence of imperatorin on the anticonvulsant and acute adverse-effect potential of lamotrigine in maximal electroshock-induced seizures and chimney test in mice. Pharmacol Rep, 2008, 60, 566-573.
22. Mendyk A, Salat K, Librowski T, Czarnecki R, Malawska B: Influence of new γ-aminobutyric acid amide derivatives and its phthalimide precursors on the central nervous system activity in mice. Pol J Pharmacol, 2001, 53, 689-693.
23. Minami E, Shibata H, Nomoto M, Fukuda T: Effect of shitei-to, a traditional Chinese medicine formulation, on pentylenetetrazol-induced kindling in mice. Phytomedicine, 2000, 7, 69-72.
24. Samuels N, Finkelstein Y, Singer SR, Oberbaum M: Herbal medicine and epilepsy: proconvulsive effects and interactions with antiepileptic drugs. Epilepsia, 2008, 49, 373-380.
25. Schachter SC: Botanicals and herbs: a traditional approach to treating epilepsy. Neurotherapeutics, 2009, 6, 415-420.
26. Stables JP, Kupferberg HJ: Chapter 16 - The NIH Anti-convulsant Drug Development (ADD) Program: preclinical anticonvulsant screening project. In: Molecular and cellular targets for anti-epileptic drugs. Eds. Avanzini G, Regesta G, Tanganelli P, Avoli M, John Libbey, London, 1997, 191-198.